Epidemiology of HTLV1 Associated Lymphoma

Year 2016, Volume: 2 Issue: 1, 77 - 81, 01.01.2016

Zahra Mozaheb

https://doi.org/10.5455/umj.20160216043925

Abstract

Introduction: In recent years, the incidence rates of many B-cell lymphomas have begun to decline in the United States, in contrast, incidence rates for T-cell lymphomas have continued to rise. T-cell lymphomas comprise multiple subtypes with different incidence rates and patterns that likely reflect their distinct etiologies. Incidence rates for lymphoid malignancies also vary by geography and there are some particular differences by subtypes. Human T-cell lymphotropic virus I HTLV-1 which is endemic in Japan and the Caribbean, northeast of Iran, resulting in elevated rates of ATLs in these regions, but in non-endemic area such as North America Peripheral T cell lymphoma PTCL is the most common T cell lymphoma. Conclusion: With multidisciplinary approaches to epidemiologic research, the major hurdles for uncovering T-cell lymphoma risk factors may finally be surmountable.

Keywords

Lymphoma, HTLV1, Epidemiology

References

• Mozaheb Z. Epidemiology of Lymphoid Malignancy in Asia: Intech; Boffetta P. I. Epidemiology of adult non-Hodgkin lymphoma. Annals of oncology. 2011;22(suppl 4):iv27-iv31.
• Engels EA. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiology Biomarkers & Prevention. 2007;16(3):401-4.
• Foss FM, Zinzani PL, Vose JM, Gascoyne RD, Rosen ST, Tobinai K. Peripheral T-cell lymphoma. Blood. 2011;117(25):6756-67.
• Harris ME. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008;26:4124-30.
• Tajima K. The 4th nation‐wide study of adult T‐cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical features. International Journal of Cancer. ;45(2):237-43. Abbaszadegan MR, Gholamin M, Tabatabaee A, Farid R, Houshmand M, Abbaszadegan M. Prevalence of human T- lymphotropic virus type 1 among blood donors from Mashhad, Iran. Journal of clinical microbiology. 2003;41(6):2593-5.
• Mozaheb Z, Aledavood A, Farzad F. Distributions of major sub- types of lymphoid malignancies among adults in Mashhad, Iran. Cancer Epidemiology. 2011;35(1):26-9.
• Ohshima K, Suzumiya J, Kikuchi M. The World Health Organization classification of malignant lymphoma: Incidence and clinical prognosis in HTLV‐1‐endemic area of Fukuoka. Pathology international. 2002;52(1):1-12.
• De Thé G, Bomford R. An HTLV-I vaccine: why, how, for whom? AIDS research and human retroviruses. 1993;9(5):381-6.
• Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K-I, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proceedings of the National Academy of Sciences. 1981;78(10):6476-80.
• Morgan OS, Mora C, Rodgers-Johnson P, Char G. HTLV-1 and polymyositis in Jamaica. The Lancet. 1989;334(8673):1184-7.
• Tarhini M, Kchour G, Zanjani DS, Rafatpanah H, Otrock ZK, Bazarbachi A, et al. Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran. Pathology. 2009;41(5):498-9.
• Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Frontiers in microbiology. ;3:388. Mueller N, Okayama A, Stuver S, Tachibana N. Findings from the Miyazaki cohort study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 1996;13:S2-S7.
• Yamaguchi K. Human T-lymphotropic virus type I in Japan. The Lancet. 1994;343(8891):213-6.
• Kakuda K, Ikematsu H, Chong WLY, Hayashi J, Kashiwagi S. Molecular epidemiology of human T lymphotropic virus type 1 transmission in Okinawa, Japan. The American journal of tropical medicine and hygiene. 2002;66(4):404-8.
• Gessain A, Gallo RC, Franchini G. Low degree of human T-cell leukemia/lymphoma virus type I genetic drift in vivo as a means of monitoring viral transmission and movement of ancient human populations. Journal of virology. 1992;66(4):2288-95.
• Liu L, Buchner E, Beitze D, Schmidt-Weber CB, Kaever V, Emmrich F, et al. Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine. International journal of immunopharmacology. 1996;18(10):529-43.
• Nerurkar VR, Song K-J, Saitou N, Melland RR, Yanagihara R. Interfamilial and intrafamilial genomic diversity and molecular phylogeny of human T-cell lymphotropic virus type I from Papua New Guinea and the Solomon Islands. Virology. 1993;196(2): 13.
• Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma. British journal of haematology. 1991;79(3):428-37.
• Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. ;50(3):481-92. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058-68.
• Mozaheb Z. Rare Presentation of Anaplastic Large Cell Lymphoma and HTLV1 Positivity: A Case Report and Review. Jacobs Journal of Hematology. 2015;1(3):16.
• Gill PS, Harrington Jr W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA, et al. Treatment of adult T-cell leukemia–lymphoma with a combination of interferon alfa and zidovudine. New England Journal of Medicine. 1995;332(26):1744-8.
• Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W, et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. Journal of Clinical Oncology. 2009;27(3):453-9.